Bio Saga Headlines

Bio Saga

Tuesday, May 18, 2010

Agilent Completes Varian Acquisition

Agilent Technologies said after the close of the market Friday that it has completed the roughly $1.5 billion acquisition of Varian.

Completion of the deal was announced a day after Agilent said that the European Commission has informed the firm that it had met the conditions set forth in January for the acquisition of Varian. Those conditions included the divestiture of certain product lines, which were recently sold to Bruker.

Agilent said today that the majority of Varian's product lines will become part of the Chemical Analysis Group, with some key businesses being housed in Agilent's Life Sciences Group. Adding to Agilent's portfolio of mass spectrometry, liquid and gas chromatography, and array products, the firm's life sciences business gains Varian's nuclear magnetic resonance, MRI, and X-ray products.

"These technology platforms will open new doors for Agilent and its customers," Nick Roelofs, Agilent's senior VP and president of LSG, said in a statement. "This technology will play a key role in Agilent's growth through applications such as pharmaceutical and therapeutics."

Agilent is scheduled to report its second-quarter 2010 financial results after the close of the market today.

No comments:

Life Science and Informatics

What is this?
is this a new industry?
or a old wine in a new bottle?

Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.

There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.

now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
their clients?

These are some interesting things that could be discussed in this blog page...

Tag It